Xi Wang

13.1k citations
268 papers · 8.9k · 2 hit papers · h-index 41

Impact in

    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research
    • Genomics and Phylogenetic Studies
    • Protein Hydrolysis and Bioactive Peptides

Papers in

    • COVID-19 Clinical Research Studies 13
    • SARS-CoV-2 and COVID-19 Research 12
    • Insect Resistance and Genetics 12
    • Viral Infectious Diseases and Gene Expression in Insects 12

Xi Wang

250 papers receiving 8.7k citations

Xi Wang's Hit Papers

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro 2020 · 1.6k citations
1.6k0+5+10Years since publication50010001.5k

Peers

Xi Wang
Comparison fields: 5 of 189
  • Infectious Diseases 1.7k
  • Molecular Biology 2.7k
  • Animal Science and Zoology 387
  • Neurology 461
  • Insect Science 377
Replace Shengyue Wang with:
Shengyue Wang China
Jian Li China
Philippe Le Mercier Switzerland
Jie Chen China
Xiao Li China
Li Lin China
Yoshihiro Yamamoto Japan
Toshio Tanaka Japan
Yifei Wang China
Min Wu China
Xi Wang relative to Shengyue Wang China Shengyue Wang's profile →
Citations per field
00.5×1.5×2.0×
Shengyue Wang · 1×
Citations per year

Countries citing papers authored by Xi Wang

Since Specialization
Citations

This map shows the geographic impact of Xi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Wang more than expected).

Fields of papers citing papers by Xi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Wang. The network helps show where Xi Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Xi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xi Wang Line = papers co-authored together Xi Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 268 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Hit paper breakdown →
20201601
2
The Arabidopsis lyrata genome sequence and the basis of rapid genome size change
Hit paper breakdown →
2011698
3 2014411
4 2006342
5 2020253
6 2011193
7 2021177
8 2015157
9 2013142
10 2016142
11 2016138
12 2022123
13 2020122
14 2015117
15 2014110
16 2018100
17 202297
18 201694
19 202092
20 201789

About Xi Wang

Xi Wang is a scholar working on Infectious Diseases, Molecular Biology, Insect Science, Animal Science and Zoology and Genetics, having authored 268 papers that have together received 8.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), COVID-19 Clinical Research Studies (13 papers), SARS-CoV-2 and COVID-19 Research (12 papers), Insect Resistance and Genetics (12 papers), Viral Infectious Diseases and Gene Expression in Insects (12 papers), Semiconductor materials and devices (12 papers), Animal Virus Infections Studies (10 papers) and Nanowire Synthesis and Applications (9 papers). The work is most often cited by research in Infectious Diseases (1.7k citations), Molecular Biology (2.7k citations), Animal Science and Zoology (387 citations), Neurology (461 citations) and Insect Science (377 citations). Xi Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Manli Wang, Zhìhóng Hú, Yufeng Li, Hengrui Hu, Wu Zhong, Ruiyuan Cao, Mingyue Xu, Huanyu Zhang, Jia Liu and Zengfeng Di. Their work appears in journals such as Nature Communications, Journal of Virology, Applied Physics Letters, Proceedings of the National Academy of Sciences and Cell Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact